eddii Appoints Dr. Kristen Mengwasser as Chief Medical Officer (CMO)
top of page
  • Writer's pictureeddii team

eddii Appoints Dr. Kristen Mengwasser as Chief Medical Officer (CMO)



eddii, a digital health company that gamifies and humanizes chronic condition management, announces Dr. Kristen Mengwasser, MD, PhD has joined the company as its Chief Medical Officer (CMO).


“In this new role, Dr. Mengwasser will provide scientific and clinical leadership, as the company continues to improve health outcomes for its users and moves towards providing clinical services in addition to its software,” said Farhaneh Ahmadi, the company’s CEO. “We are very excited to have Kristen’s expertise and leadership as our product enters the market and the company continues to find ways to serve the diabetes and healthcare communities.”


“It is my pleasure and honor to be joining the team at eddii. eddii’s service has been shown to improve health outcomes, without any adverse effects to patients. Providing motivation and support in the management of chronic conditions is a powerful method toward our collective goal of improving human health”, stated Dr. Mengwasser.


Kristen, a graduate of the MD-PhD program at Harvard Medical School, completed her residency in internal medicine at Brigham and Women’s Hospital. She completed her Masters in Biochemistry at Cambridge University and holds a bachelor’s degree in Biological and Biomedical Sciences from Harvard. She is currently completing her fellowship at UCSF. Dr. Mengwasser is a licensed physician in the state of California.


About eddii

eddii is a virtual in-app character designed to engage people living with diabetes to track and record their health. Through gamification and witty conversation, eddii becomes a smart, virtual health buddy, providing users with weekly health reports and collectible in-app items in return for data entry. Our mission is to motivate everyone living with diabetes to record their wellness daily and adhere to healthy routines, leading to better outcomes.

210 views0 comments
bottom of page